Research Projects: As PI in 11 projects financed in competitive calls, 8 in national calls and 3 internacional calls, in 2019 from Ferring Research Institute, in 2022 from Transcan 3 JTC-21 and Caixa Impulse Program in 2023. As research team in 22 projects.

Courses Organization: I have organized and being scientific director of 4 international courses (1997, 2003, 2005 and 2006) and 2 national courses (2002 and 2022).

Direction of Research Lines: In 1996-99 Leader of scFv expression group in bacteriophages as diagnostic and clinical tools (CIGB, Cuba). During 2000-07 I was Head of the Genomics Department directing 14 researchers in Population genomics projects (CIGB, Cuba). Since 2015, I have led the study of the Tumor-immune system interactome in bladder cancer and the use of Liquid biopsy in bladder cancer screening and prognosis (CIEMAT, Spain) currently directing 7 researchers.

Thesis Direction: I have directed 2 doctoral theses (2011 UH, Cuba and 2019 UCM, Madrid), and I currently directing 6 other predoctoral students, one international co-directed with Dra, C. Jerónimo from IPO-Porto, 9 master thesis, and 9 end of degree thesis.

Teaching Activity: I was professor of the national degree program of the School of Biology at Havana University (2003-07). Professor of the postgraduate course of the Biology Sciences Doctoral Program “Advanced Strategies in Molecular Biology” (2004, 05 and 06). Professor of Master's Degree in Thoracic Oncology at the CEU-Cardenal Herrera University “Molecular Bases of Cancer” thematic area 2017-2023. Professor at the Latin American Forum of training of specialists in genitourinary cancer. Hosp. October 12, 2016 and 2017.

Other merits: I was a permanent member of the National Committee of Biological Sciences, Cuba and Expert in PROFARMA Committee of the Industry Ministry, Madrid, Spain.

Dr. Caterina Marchiò is an experimental pathologist leading the research programme of the Pathology Unit at the Candiolo Cancer Institute.

Dr. Marchiò completed her undergraduate training at the University of Turin and undertook a PhD programme during which she trained at Breakthrough Breast Cancer Research Centre – Institute of Cancer Research in London. Upon the completion of the PhD she undertook her clinical training in Pathology at the University of Turin. She was then appointed Associate Professor of Pathology for the University of Turin at the Candiolo Cancer Institute FPO-IRCCS.

Dr. Marchiò is devoted to deconvolute the complexity of pathology to foster precision medicine. She is also actively involved in the standardisation of preanalytical conditions of tissue sample management and processing to guarantee quality of DNA, RNA and antigens.

She has been involved in the ESMO Translational Research and Precision Medicine Working Group and led the consensus recommendation paper on the standard methods to detect NTRK fusions in daily practice and clinical research.